STRYKER CORP Segment Reporting Information, Income Tax Expense (Benefit) (Deprecated 2011-01-31)
STRYKER CORP (SYK) reported Segment Reporting Information, Income Tax Expense (Benefit) (Deprecated 2011-01-31) of $499.60 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-18.
Discontinued › Expense Statement › Income Tax
us-gaap:SegmentReportingInformationIncomeTaxExpenseBenefit · last filed 2011-02-18
- STRYKER CORP segment reporting information, income tax expense (benefit) (deprecated 2011-01-31) for fiscal 2010 was $499.60M, a 11.44% increase from fiscal 2009.
- STRYKER CORP segment reporting information, income tax expense (benefit) (deprecated 2011-01-31) for fiscal 2009 was $448.30M, a 0.61% increase from fiscal 2008.
- STRYKER CORP segment reporting information, income tax expense (benefit) (deprecated 2011-01-31) for fiscal 2008 was $445.60M.
| Period end | Segment Reporting Information, Income Tax Expense (Benefit) (Deprecated 2011-01-31) 12 month |
|---|---|
| 2010-12-31 | $499.60M 10-K · filed 2011-02-18 |
| 2009-12-31 | $448.30M 10-K · filed 2011-02-18 |
| 2008-12-31 | $445.60M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |